Carter Bankshares (CARE) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $30.31, +0.93% vs the prior close of $30.03.
- Volume 113.40K shares, 0.4x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
CARE rises 0.9% to $30.31. Closed at $30.31, +0.93% vs the prior close of $30.03. Day range $30.06–$30.58, opened at $30.24.
CARE daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — CARE rises 0.9% to $30.31
- Closed at $30.31, +0.93% vs the prior close of $30.03. Day range $30.06–$30.58, opened at $30.24.
- Volume was 113.40K shares, 0.4x its 50-day average of 282.23K — lighter than usual.
- Price is -2.5% vs its 50-day average ($31.09) and +12.6% vs its 200-day average ($26.91).
- 52-week range $16.78–$36.06; today's close sits at 70% of that range, 15.9% below the 52-week high.
Oct 14, 2026 — CARE dips 0.5% to $30.03
- Closed at $30.03, -0.53% vs the prior close of $30.19. Day range $29.67–$30.23, opened at $29.67.
- Volume was 197.30K shares, 0.7x its 50-day average of 287.00K.
- Price is -3.7% vs its 50-day average ($31.19) and +11.8% vs its 200-day average ($26.86).
- 52-week range $16.78–$36.06; today's close sits at 69% of that range, 16.7% below the 52-week high.
Oct 13, 2026 — CARE dips 0.4% to $30.19
- Closed at $30.19, -0.36% vs the prior close of $30.30. Day range $30.02–$30.58, opened at $30.50.
- Volume was 121.20K shares, 0.4x its 50-day average of 295.47K — lighter than usual.
- Price is -3.5% vs its 50-day average ($31.30) and +12.6% vs its 200-day average ($26.81).
- 52-week range $16.78–$36.06; today's close sits at 70% of that range, 16.3% below the 52-week high.
Oct 12, 2026 — CARE rises 0.5% to $30.30
- Closed at $30.30, +0.46% vs the prior close of $30.16. Day range $30.16–$30.72, opened at $30.16.
- Volume was 135.10K shares, 0.4x its 50-day average of 302.33K — lighter than usual.
- Price is -3.5% vs its 50-day average ($31.40) and +13.3% vs its 200-day average ($26.75).
- 52-week range $16.78–$36.06; today's close sits at 70% of that range, 16.0% below the 52-week high.
Oct 9, 2026 — CARE dips 1.0% to $30.16
- Closed at $30.16, -1.02% vs the prior close of $30.47. Day range $30.14–$30.47, opened at $30.47.
- Volume was 158.40K shares, 0.5x its 50-day average of 308.00K — lighter than usual.
- Price is -4.2% vs its 50-day average ($31.49) and +13.0% vs its 200-day average ($26.70).
- 52-week range $16.78–$36.06; today's close sits at 69% of that range, 16.4% below the 52-week high.
Oct 8, 2026 — CARE rises 0.9% to $30.47
- Closed at $30.47, +0.93% vs the prior close of $30.19. Day range $29.96–$30.56, opened at $30.05.
- Volume was 194.20K shares, 0.6x its 50-day average of 311.56K.
- Price is -3.5% vs its 50-day average ($31.57) and +14.3% vs its 200-day average ($26.65).
- 52-week range $16.78–$36.06; today's close sits at 71% of that range, 15.5% below the 52-week high.
Oct 7, 2026 — CARE dips 0.9% to $30.19, 3 down days in a row
- Closed at $30.19, -0.89% vs the prior close of $30.46. Day range $29.92–$30.34, opened at $30.17.
- Volume was 144.20K shares, 0.5x its 50-day average of 319.07K — lighter than usual.
- Price is -4.6% vs its 50-day average ($31.65) and +13.5% vs its 200-day average ($26.60).
- 52-week range $16.78–$36.06; today's close sits at 70% of that range, 16.3% below the 52-week high.
- That makes 3 straight losses.
Oct 6, 2026 — CARE ends flat (-0.3%) to $30.46
- Closed at $30.46, -0.29% vs the prior close of $30.55. Day range $30.33–$30.77, opened at $30.45.
- Volume was 128.00K shares, 0.4x its 50-day average of 324.95K — lighter than usual.
- Price is -4.0% vs its 50-day average ($31.74) and +14.7% vs its 200-day average ($26.55).
- 52-week range $16.78–$36.06; today's close sits at 71% of that range, 15.5% below the 52-week high.
Oct 5, 2026 — CARE dips 0.7% to $30.55
- Closed at $30.55, -0.65% vs the prior close of $30.75. Day range $30.41–$30.71, opened at $30.67.
- Volume was 121.70K shares, 0.4x its 50-day average of 330.95K — lighter than usual.
- Price is -4.0% vs its 50-day average ($31.81) and +15.3% vs its 200-day average ($26.50).
- 52-week range $16.78–$36.06; today's close sits at 71% of that range, 15.3% below the 52-week high.
Oct 2, 2026 — CARE rises 1.3% to $30.75
- Closed at $30.75, +1.28% vs the prior close of $30.36. Day range $30.49–$30.99, opened at $30.70.
- Volume was 125.80K shares, 0.4x its 50-day average of 336.93K — lighter than usual.
- Price is -3.5% vs its 50-day average ($31.88) and +16.3% vs its 200-day average ($26.45).
- 52-week range $16.78–$36.06; today's close sits at 72% of that range, 14.7% below the 52-week high.
CARE latest news & SEC filings
Every SEC filing by or about CARE in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 8, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Sep 11, 2026 · Form 4/A — Insider trade (amended)
Amended insider trade report (Form 4/A)
- Midkiff Catharine L. sold 1,000 shares at $31.25 (≈$31.25K) on Sep 11, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 11, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Midkiff Catharine L. sold 1,000 shares at $31.25 (≈$31.25K) on Sep 11, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 17, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 11, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Aug 6, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: $28.91M (prior year $8.51M) (+239.7% vs Jun 30, 2025)
- Diluted EPS: $1.31 (prior year $0.37) (+254.1% vs Jun 30, 2025)
Aug 5, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 31, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 30, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Bolton Robert M. sold 1,500 shares at $34.60 (≈$51.90K) on Jul 30, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Jul 30, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Langs Bradford N. sold 2,500 shares at $34.54 (≈$86.35K) on Jul 30, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Jul 27, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Jul 23, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Jul 23, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Things to know before you trade CARE
- Last results release: Jul 23, 2026 (8-K Item 2.02). Previous ones: Apr 23, 2026, Jan 29, 2026, Oct 23, 2025. Based on that rhythm, the next report is likely around Oct 22, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 0.93% (largest 2.1%). That is a relatively calm stock.
- Liquidity: about 237.84K shares (≈$7.21M) trade per day on average.
- 52-week position: $30.31 vs a range of $16.78–$36.06 (70% of the range).
- Dividends: last ex-dividend date Aug 10, 2026 ($0.1/share); 2 payments in the past 12 months.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 1 open-market buys, 7 sales; latest: Catharine L. Midkiff sold 1,000 shares on Sep 11, 2026.
- Latest filings: 8-K Aug 17, 2026; 8-K Aug 11, 2026; 10-Q Aug 6, 2026.
- Share count: 22.16M shares outstanding (Aug 3, 2026), -2.2% vs a year earlier — the company has been reducing its share count.
- Listing: Nasdaq · industry: National Commercial Banks.
CARE market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 30.24 | 30.58 | 30.06 | 30.31 | 113.40K |
| Oct 14, 2026 | 29.67 | 30.23 | 29.67 | 30.03 | 197.30K |
| Oct 13, 2026 | 30.50 | 30.58 | 30.02 | 30.19 | 121.20K |
| Oct 12, 2026 | 30.16 | 30.72 | 30.16 | 30.30 | 135.10K |
| Oct 9, 2026 | 30.47 | 30.47 | 30.14 | 30.16 | 158.40K |
| Oct 8, 2026 | 30.05 | 30.56 | 29.96 | 30.47 | 194.20K |
| Oct 7, 2026 | 30.17 | 30.34 | 29.92 | 30.19 | 144.20K |
| Oct 6, 2026 | 30.45 | 30.77 | 30.33 | 30.46 | 128.00K |
| Oct 5, 2026 | 30.67 | 30.71 | 30.41 | 30.55 | 121.70K |
| Oct 2, 2026 | 30.70 | 30.99 | 30.49 | 30.75 | 125.80K |
| Oct 1, 2026 | 29.73 | 30.45 | 29.36 | 30.36 | 273.80K |
| Sep 30, 2026 | 30.04 | 30.32 | 29.65 | 29.89 | 251.10K |
| Sep 29, 2026 | 29.62 | 30.21 | 29.45 | 30.12 | 281.80K |
| Sep 28, 2026 | 30.38 | 30.38 | 29.60 | 29.66 | 217.50K |
| Sep 25, 2026 | 30.12 | 30.35 | 29.89 | 30.31 | 184.70K |
| Sep 24, 2026 | 29.99 | 30.21 | 29.93 | 30.07 | 578.70K |
| Sep 23, 2026 | 30.18 | 30.66 | 29.88 | 29.93 | 200.50K |
| Sep 22, 2026 | 30.94 | 30.95 | 30.06 | 30.28 | 291.30K |
| Sep 21, 2026 | 30.79 | 30.95 | 30.56 | 30.70 | 162.60K |
| Sep 18, 2026 | 30.16 | 30.91 | 29.82 | 30.79 | 875.60K |
About Carter Bankshares
Carter Bankshares (CARE) is listed on the Nasdaq and classified by the SEC under “National Commercial Banks”. Its business address is in MARTINSVILLE, VA. State of incorporation: VA. Fiscal year ends December 31. SEC CIK 1829576.
CARE board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Michael R Bird | Director | Jan 5, 2026 |
| Kevin S. Bloomfield | Director | Jan 5, 2026 |
| Robert M. Bolton | Director | Jul 30, 2026 |
| Gregory W Feldmann | Director | Aug 5, 2026 |
| James W. Haskins | Director | May 6, 2026 |
| Phyllis Q. Karavatakis | Director | Jan 5, 2026 |
| Jacob A Iii Lutz | Director | Jan 5, 2026 |
| Catharine L. Midkiff | Director | Sep 11, 2026 |
| Curtis E Stephens | Director | Jan 5, 2026 |
| Dyke Litz H Van | CHIEF EXECUTIVE OFFICER | Jul 2, 2026 |
| Elizabeth L. Walsh | Director | May 11, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Arthur Loran Adams | EVP, DIRECTOR OF REG RISK MNGT | Jul 2, 2026 |
| Wendy S. Bell | SENIOR EXECUTIVE VP, CFO | Jul 2, 2026 |
| Jane Ann Davis | EVP, CHIEF ADMIN. OFFICER | Jul 2, 2026 |
| Tony E Kallsen | SEVP, CHIEF CREDIT OFFICER | Jul 2, 2026 |
| Bradford N. Langs | PRESIDENT, CHIEF STRATEGY OFCR | Jul 30, 2026 |
| Matthew M. Speare | SEVP, CHIEF OPERATING OFFICER | Jul 2, 2026 |
| Dyke Litz H Van | CHIEF EXECUTIVE OFFICER | Jul 2, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 11, 2026 | Catharine L. Midkiff | Sale | 1,000 | $31.25 |
| Sep 11, 2026 | Catharine L. Midkiff | Sale | 1,000 | $31.25 |
| Jul 30, 2026 | Bradford N. Langs | Sale | 2,500 | $34.54 |
| Jul 30, 2026 | Robert M. Bolton | Sale | 1,500 | $34.60 |
| May 12, 2026 | Bradford N. Langs | Sale | 5,500 | $26.47 |
| May 6, 2026 | Elizabeth L. Walsh | Buy | 4,575 | $26.20 |
| May 5, 2026 | James W. Haskins | Sale | 1,000 | $26.04 |
| Oct 30, 2025 | Robert M. Bolton | Sale | 1,901 | $17.23 |
CARE financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $20.32M | $31.36M | 1.38 | $39.86M |
| Dec 31, 2024 | $19.41M | $24.52M | 1.06 | $36.94M |
| Dec 31, 2023 | $17.27M | $23.38M | 1.00 | $46.73M |
| Dec 31, 2022 | $18.33M | $50.12M | 2.03 | $70.79M |
| Dec 31, 2021 | $17.49M | $31.59M | 1.19 | $77.54M |
Latest balance sheet: total assets $4.80B, total liabilities $4.26B, cash $276.54M (as of Jun 30, 2026).
CARE earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Jul 23, 2026 | 8-K Item 2.02 (results) | $33.90 |
| Apr 23, 2026 | 8-K Item 2.02 (results) | $23.86 |
| Jan 29, 2026 | 8-K Item 2.02 (results) | $20.48 |
| Oct 23, 2025 | 8-K Item 2.02 (results) | $17.74 |
| Jul 24, 2025 | 8-K Item 2.02 (results) | $18.57 |
| Apr 24, 2025 | 8-K Item 2.02 (results) | $15.69 |
| Jan 23, 2025 | 8-K Item 2.02 (results) | $17.78 |
| Oct 24, 2024 | 8-K Item 2.02 (results) | $18.29 |
| Jul 25, 2024 | 8-K Item 2.02 (results) | — |
| Apr 25, 2024 | 8-K Item 2.02 (results) | — |
| Jan 25, 2024 | 8-K Item 2.02 (results) | — |
| Oct 26, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · National Commercial Banks
JPMorgan Chase (JPM)Bank of America (BAC)Wells Fargo (WFC)Citigroup (C)Capital One Financial (COF)Pnc Financial Services (PNC)Us Bancorp \De\ (USB)Huntington Bancshares (HBAN)Truist Financial (TFC)Keycorp (KEY)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on CARE
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.